|
Model Number 501DM18 |
Device Problem
Insufficient Information (3190)
|
Patient Problem
Mitral Valve Insufficiency/ Regurgitation (4451)
|
Event Date 08/14/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that 3 months post implant of this 18mm mitral mechanical valve in this (b)(6) pediatric patient, it was explanted and replaced with an unknown product.The reason for the replacement was reported as "common atrioventricular valve regurgitation".No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Product analysis: upon receipt at medtronic's quality laboratory, visual examination revealed that the sewing cuff was partially removed exposing the stiffening ring, which likely occurred during the explant procedure.Both leaflets were received in the closed position.A blue actuator was used to test leaflet movement; the leaflets moved without difficulty.All leaflets were intact with no evidence of damage such as cracks and/or surface anomalies.Both hinge mechanisms were intact with no evidence of damage.The orifice was intact with no defects observed.Traces of pannus were observed along the sewing cuff.Radiography did not reveal calcification on the returned valve.Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.H3: device evaluated? updated h6: coding updated medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H6: coding corrected investigation conclusion: with the limited received information and normal performance of the device during product analysis, the cause of the regurgitation cannot be determined.Regurgitation can be caused by a variety of factors, including implant condition/position, patient anatomy, or presence of pre-existing patient conditions.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|